Long-Term Results of Sodium 2-Mercaptoethane Sulfonate Usage on Cholesteatoma Surgery

Basit Öğe Kaydı
dc.authorscopusid57207623667
dc.authorscopusid57210185459
dc.authorscopusid57204596191
dc.authorscopusid55539427200
dc.authorscopusid6602540278
dc.contributor.authorCelik S.
dc.contributor.authorYalcın M.Z.
dc.contributor.authorKılıc O.
dc.contributor.authorTan M.
dc.contributor.authorKalcioglu M.T.
dc.date.accessioned2024-08-04T20:02:17Z
dc.date.available2024-08-04T20:02:17Z
dc.date.issued2024
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBACKGROUND: Although advanced technologies and surgical procedures are used, cholesteatoma is a disease with the possibility of recurrence. The aim of this study was to determine the long-term effect of sodium 2-mercaptoethane sulfonate (MESNA) on cholesteatoma surgery. METHODS: Patients who underwent cholesteatoma surgery between January 2009 and July 2014 by the same surgeon were divided into 2 groups: those where MESNA was used and those where it was not. Otomicroscopic examinations were performed to see the presence of cholesteatoma recurrence in the patients who had surgery at least 8 years ago. Pure-tone audiometry was performed to evaluate the hearing results. RESULTS: Sodium 2-mercaptoethane sulfonate was used in 23 patients and was not used in 39 patients who came to the control. In the MESNA-used group, cholesteatoma was seen in only 1 of the patients who underwent a canal wall-down (CWD) mastoidectomy. In the MESNA non-used group, cholesteatoma was seen in 3 patients who underwent CWD. The difference was not statistically significant. CONCLUSION: Although there was no statistically significant difference, recurrence of cholesteatoma was seen less frequently in patients who received MESNA during surgery. Studies to be conducted in larger patient series may clarify this issue. © 2024, AVES. All rights reserved.en_US
dc.identifier.doi10.5152/iao.2024.231208
dc.identifier.endpage235en_US
dc.identifier.issn1308-7649
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85195285052en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage231en_US
dc.identifier.urihttps://doi.org/10.5152/iao.2024.231208
dc.identifier.urihttps://hdl.handle.net/11616/91565
dc.identifier.volume20en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherAVESen_US
dc.relation.ispartofJournal of International Advanced Otologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCholesteatomaen_US
dc.subjectmastoidectomyen_US
dc.subjectMESNAen_US
dc.titleLong-Term Results of Sodium 2-Mercaptoethane Sulfonate Usage on Cholesteatoma Surgeryen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu